Voglibose with Repaglinide

Voglibose with Repaglinide is a combination medication used in the management of Type 2 diabetes mellitus. It contains two active ingredients, voglibose and repaglinide, which work together to regulate blood sugar levels.

Indications

This combination is indicated for the treatment of Type 2 diabetes mellitus when diet and exercise alone do not provide adequate glycemic control.

Dosage

The dosage of Voglibose with Repaglinide should be individualized based on the patient's response and blood glucose levels. It is typically taken orally before meals.

Contra-Indications

-Hypersensitivity to voglibose, repaglinide, or any component of the formulation. -Type 1 diabetes mellitus. -Diabetic ketoacidosis. -Severe hepatic impairment.

Special Precautions

-Regular monitoring of blood glucose levels is essential. -Caution in patients with renal impairment. -Use with caution in elderly patients. -Adjust dosage during periods of increased or decreased physical activity.

Side Effects

Common side effects may include hypoglycemia, gastrointestinal disturbances (such as flatulence, diarrhea), and headache. Rare but severe side effects may include hepatic dysfunction.

Drug Interactions

-Increased risk of hypoglycemia when combined with other antidiabetic agents. -Potential interaction with certain medications that affect liver enzymes (e.g., ketoconazole, gemfibrozil). -Concomitant use with beta-blockers may mask symptoms of hypoglycemia.